This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Macular Hole or Surgery
and you are
between 50 and 80
years old
-
The phase for this study is not defined.
Show me locations

The purpose

To compare the morphologic and functional outcomes of internal limiting membrane peeling-reposition versus peeling in idiopathic macular holes

Provided treatments

  • Procedure: peeling-reposition
  • Procedure: peeling
  • Drug: Brilliant Blue G
  • Other: postoperative posture
  • Device: Constellation 23-gauge vitrectomy system

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03020459. The sponsor of the trial is Xinhua Hospital, Shanghai Jiao Tong University School of Medicine and it is looking for 30 volunteers for the current phase.
Official trial title:
Comparing the Surgical Outcomes of Internal Limiting Membrane Peeling-reposition Versus Peeling in Idiopathic Macular Holes: A Randomized Controlled Trial